DrugCite
Search

ZARATOR

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Zarator Adverse Events Reported to the FDA Over Time

How are Zarator adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Zarator, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Zarator is flagged as the suspect drug causing the adverse event.

Most Common Zarator Adverse Events Reported to the FDA

What are the most common Zarator adverse events reported to the FDA?

Myalgia
11 (3.63%)
Multi-organ Failure
7 (2.31%)
Arthralgia
6 (1.98%)
Asthenia
6 (1.98%)
Choluria
6 (1.98%)
Diarrhoea
6 (1.98%)
Pancreatitis
6 (1.98%)
Vomiting
6 (1.98%)
Dizziness
5 (1.65%)
Drug Interaction
5 (1.65%)
Dyspnoea
5 (1.65%)
Show More Show More
Hepatic Necrosis
5 (1.65%)
Jaundice Cholestatic
5 (1.65%)
Neutropenia
5 (1.65%)
Cystitis
4 (1.32%)
Faeces Discoloured
4 (1.32%)
Fatigue
4 (1.32%)
Hallucination
4 (1.32%)
Hepatitis Toxic
4 (1.32%)
Myelitis Transverse
4 (1.32%)
Visual Impairment
4 (1.32%)
Yellow Skin
4 (1.32%)
Alopecia
3 (.99%)
Amyotrophic Lateral Sclerosis
3 (.99%)
Cough
3 (.99%)
Dysuria
3 (.99%)
Ecchymosis
3 (.99%)
Feeling Abnormal
3 (.99%)
Haematuria
3 (.99%)
Headache
3 (.99%)
Hyperkalaemia
3 (.99%)
Hypotension
3 (.99%)
Hypothyroidism
3 (.99%)
Jaundice
3 (.99%)
Palpitations
3 (.99%)
Product Formulation Issue
3 (.99%)
Respiratory Disorder
3 (.99%)
Sleep Disorder
3 (.99%)
Spontaneous Haematoma
3 (.99%)
Tinnitus
3 (.99%)
Tongue Oedema
3 (.99%)
Transaminases Increased
3 (.99%)
Abasia
2 (.66%)
Angina Pectoris
2 (.66%)
Anorexia
2 (.66%)
Blindness Unilateral
2 (.66%)
Blood Alkaline Phosphatase Increase...
2 (.66%)
Blood Creatine Phosphokinase Increa...
2 (.66%)
Blood Glucose Decreased
2 (.66%)
Chest Pain
2 (.66%)
Convulsion
2 (.66%)
Drug Ineffective
2 (.66%)
Dyspepsia
2 (.66%)
Enanthema
2 (.66%)
Eye Swelling
2 (.66%)
Gait Disturbance
2 (.66%)
Gamma-glutamyltransferase Increased
2 (.66%)
Gynaecomastia
2 (.66%)
Hepatitis
2 (.66%)
Hip Arthroplasty
2 (.66%)
Laryngeal Oedema
2 (.66%)
Liver Disorder
2 (.66%)
Lower Limb Fracture
2 (.66%)
Muscle Spasms
2 (.66%)
Muscular Weakness
2 (.66%)
Optic Nerve Infarction
2 (.66%)
Polyneuropathy
2 (.66%)
Pruritus
2 (.66%)
Pseudomembranous Colitis
2 (.66%)
Pulmonary Fibrosis
2 (.66%)
Rash
2 (.66%)
Rash Maculo-papular
2 (.66%)
Rhabdomyolysis
2 (.66%)
Swelling Face
2 (.66%)
Swollen Tongue
2 (.66%)
Urticaria
2 (.66%)
Abdominal Pain
1 (.33%)
Abortion Induced
1 (.33%)
Adverse Drug Reaction
1 (.33%)
Alanine Aminotransferase Increased
1 (.33%)
Amnesia
1 (.33%)
Arrhythmia
1 (.33%)
Ataxia
1 (.33%)
Biliary Tract Disorder
1 (.33%)
Blood Cholesterol Increased
1 (.33%)
Blood Creatine Phosphokinase
1 (.33%)
Blood Glucose Increased
1 (.33%)
Cholelithiasis
1 (.33%)
Cholestasis
1 (.33%)
Constipation
1 (.33%)
Death
1 (.33%)
Decreased Appetite
1 (.33%)
Dementia
1 (.33%)
Depression
1 (.33%)
Dermatofibrosarcoma
1 (.33%)
Diabetes Mellitus
1 (.33%)
Diplopia
1 (.33%)
Drug Eruption
1 (.33%)
Drug Exposure During Pregnancy
1 (.33%)
Drug Hypersensitivity
1 (.33%)
Drug Intolerance
1 (.33%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Zarator, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Zarator is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Zarator

What are the most common Zarator adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Zarator, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Zarator is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Zarator According to Those Reporting Adverse Events

Why are people taking Zarator, according to those reporting adverse events to the FDA?

Hypercholesterolaemia
64
Hyperlipidaemia
19
Dyslipidaemia
19
Drug Use For Unknown Indication
17
Blood Cholesterol Increased
8
Blood Cholesterol
5
Show More Show More
Ill-defined Disorder
5
Acute Myocardial Infarction
5
Cerebrovascular Accident Prophylaxi...
3
Blood Cholesterol Abnormal
2
Spinal Cord Disorder
2
Low Density Lipoprotein Increased
1
Myocardial Ischaemia
1
Type Iia Hyperlipidaemia
1
Cardiac Disorder
1

Zarator Case Reports

What Zarator safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Zarator. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Zarator.